NFLX
74
4
TGNA
50
2
CINF
38
3
PAYX
45
6
CHD
37
5
MCHP
37
3
KMB
31
3
ABBV
48
2
PEP
36
3
CRM
67
2
ACN
54
4
BMY
33
-2
ALLE
25
4
MS
70
6
RHI
50
2
NWS
75
6
DVN
22
2
MCD
57
5
WMT
68
2
VNO
49
2
NFLX
74
4
TGNA
50
2
CINF
38
3
PAYX
45
6
CHD
37
5
MCHP
37
3
KMB
31
3
ABBV
48
2
PEP
36
3
CRM
67
2
ACN
54
4
BMY
33
-2
ALLE
25
4
MS
70
6
RHI
50
2
NWS
75
6
DVN
22
2
MCD
57
5
WMT
68
2
VNO
49
2
Financhill
Back

Laird Superfood 10K Form

Sell
37

LSF
Laird Superfood

Last Price:
$8.40
Seasonality Move:
23.82%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive LSF News And Ratings

See the #1 stock for the next 7 days that we like better than LSF

LSF Financial Statistics

Sales & Book Value

Annual Sales: $34.2M
Cash Flow: $305.8K
Price / Cash Flow: 109.85
Annual Sales: $1.27
Price / Book: 6.14

Profitability

EPS (TTM): -0.13000
Net Income (TTM): $-1.3M
Gross Margin: $10.3M
Return on Equity: -9.88%
Return on Assets: -6.96%

Laird Superfood Earnings Forecast

Key Laird Superfood Financial Ratios

  • The Gross Profit Margin over the past 6 years for LSF is 30.13%.
  • The Selling, General & Administrative Expenses for LSF have been equal to 60.75% of Gross Profit Margin.
  • The Research & Development expenses have been 0.64% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of LSF is -29.70% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 2 years.

Laird Superfood Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Food Products
Sector: Consumer Staples
Current Symbol: LSF
CUSIP: 50736T
Website: lairdsuperfood.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 3.13
Quick Ratio: 1.75

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

LSF Technical Analysis vs Fundamental Analysis

Sell
37
Laird Superfood (LSF) is a Sell

Is Laird Superfood a Buy or a Sell?

  • Laird Superfood stock is rated a Sell
    The current Laird Superfood [LSF] share price is $7.80. The Score for LSF is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.